CBEX’s primary advisory activities are M&A and the provision of other structured products tailored to meet the specific strategic needs of our clients. We offer highly professional M&A advisory services, provided by senior staff with a track record developed at leading international investment banks. Our M&A credentials include the successful execution of a large number of transactions across many industrial sectors in the African continental, European Countries, Asia, America, as well as former Soviet Union. Products include sell-side and buy-side M&A, public offers, tender offers, restructurings and management buyout, leveraged buyout.
Being creative in approaching our clients’ needs is a key differentiating factor of our organization. CBEX has successfully completed a number of structured transactions with innovative products. Most notably, CBEX has developed structured equity and equity-linked products, including redeemable cumulative convertible preference shares, convertible bonds, participation notes, recapitalizations and structured products which have all been designed and successfully executed by CBEX.
To adapt to radical changes that have been enforced on the incumbent business model for the equity research product and to capitalize on the strength of our research capability, CBEX has adopted a model which enables us to provide the highest quality equity research in any sector for our clients.
This model continues to be used by the firm to deliver dedicated equity research which is utilized to market and execute equity capital markets and corporate broking business. We have contracted with Chinese commercial analysts and over 20 highly ranked American and European equity analysts who write specialist research, comprising company specific reports as well as technical analysis and overview sector research. Analysts have typically been contracted for research preparation on a deal-by-deal basis.